| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Evoke Pharma Inc
13D
EVOK · 30049G302
|
10.5% |
11/12/2025
Event 11/4/2025
|
||||
| Klein Roger M. | 10.5% | |||||
| Krieger Charitable Trust | 8.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.